TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search results
Indonesia temporarily banned sales of some syrup-based medications in October after it identified the presence in some products of ethylene glycol and diethylene glycol as possible factors for causing the illness.
The National Police’s Criminal Investigation Department (Bareskrim) is considering criminal charges against two pharmaceutical companies for producing toxic medicines that have caused a spike in acute kidney injury (AKI) cases.
The decision by the BPOM agency came after the government temporarily banned sales of some syrup-based medications and identified the presence in some products of ethylene glycol and diethylene glycol as possible factors in the AKI deaths, most of which were of children under five.
The Food and Drug Monitoring Agency (BPOM) has alleged that cost-cutting measures by drug manufacturers are to blame for toxic medicines that have caused a recent spike in acute kidney injury (AKI) cases, which has left dozens of children dead this year.
The Indonesian Ombudsman has pointed to potential maladministration by the Food and Drug Monitoring Agency (BPOM) and the Health Ministry in the circulation of medicines that have been linked to the deadly spike in acute kidney injury (AKI) cases among children.
Health authorities have temporarily banned sales of some syrup-based medications and identified the presence in some products of ethylene glycol and diethylene glycol as possible factors in the deaths of 141 children, most of which were under five.
As a probe continues into rising cases of acute kidney injury (AKI) that have so far killed more than 100 children, the drug regulator said it was not conducting inspections on medicinal syrups that were currently on the market, but planned on revising this stance going forward.
Consumer groups, lawmakers and pharmacists are calling for more action by the Food and Drug Monitoring Agency (BPOM) following its decision to order several medicinal syrups to be recalled from the market over their possible links to fatal kidney injuries among almost 100 children.
